Basilea Pharmaceutica Ltd.

Swiss Biotech Association

Member

Basilea Pharmaceutica Ltd. is a commercial stage biopharmaceutical company headquartered in Basel, Switzerland and listed on the SIX Swiss Exchange (SIX: BSLN). It focuses on the development of products that address the medical challenges in the therapeutic areas of oncology and anti-infectives.

https://www.basilea.com
+41 61 606 11 11
info_basilea@basilea.com
Dr. Peer Nils Schröder

Location

Hegenheimermattweg 167b, 4123 Allschwil, Switzerland

Get Directions

Facts & figures

Type of organization

Public company
Year of foundation

2000
Number of employees in Switzerland

150-249

Key business

Core competencies

Therapeutics/vaccines (human)

You may also be interested in

plusbiome AG

plusbiome AG is a Swiss startup company working at the interface of digital health and the microbiome. We design and market customised probiotics that truly support customers and their well-being,. Customers also profit from accompanying Apps.
4057 Basel

Member

SOMAGENETIX AG

Somagenetix is a Spin-off from the Univ of Zurich leveraging scientific, clinical and commercial expertise to solve unmet medical needs through gene therapy. We aim at becoming a leading gene therapy company with first-in-class and best-in-class treatment for phagocyte-related disorders.
8047 Zürich

Member

Adoram Therapeutics SA

Adoram Therapeutics is developing a suite of small molecule allosteric modulators for different indications. Our primary asset in the preclinical stage, is a negative allosteric modulator (NAM) of a clinically validated immuno-oncology target - the adenosine 2A receptor (A2AR).
1212 Grand-Lancy

Member